推进医疗器械临床研究成果转化暨"春雨行动"工作推进会召开 12月4日，国家药监局官微发文显示，日前，推进医疗器械临床研究成果转化暨"春雨行动"工作推进会 在广州召开。会议全面总结"春雨行动"阶段性成效，深入分析试点面临的困难，研究部署下一步工作安 排。会议要求，各参与试点省份要准确把握"春雨行动"的关键环节，继续加强政策宣贯培训，做好项目 征集和评估筛选，积极开展分类指导服务，推动项目匹配对接，完善跨部门协同工作机制，强化注册服 务能力建设，推进以临床价值为导向的医疗器械源头创新，推动"春雨行动"从试点省份探索转向全国常 态化运行，加快产品上市进程。 187个化药集采启动 政策动向 12月3日，中纪委官网发布要闻《来自监督一线的报道丨拧紧医保基金"安全阀"》谈到，在山西省太原 市纪委监委牵头推动下，太原市医保局开展了新一轮医保基金领域问题线索集中筛查。借助大数据信息 化技术，着力排查骗保、套保等问题线索，并进行实地检查核查，依规依法作出处理。 21点评：随着一桩桩骗保案被不断挖出，其背后的腐败链条也被斩断。在跨部门协同、大数据监管、严 肃问责与持续性整改的过程中，基金安全的防线也将更加坚实。 药械审批 新华医 ...

据国家药监局消息，12月3日，推进医疗器械临床研究成果转化暨"春雨行动"工作推进会在广州召开。 会议要求，各参与试点省份要准确把握"春雨行动"的关键环节，继续加强政策宣贯培训，做好项目征集 和评估筛选，积极开展分类指导服务，推动项目匹配对接，完善跨部门协同工作机制，强化注册服务能 力建设，推进以临床价值为导向的医疗器械源头创新，推动"春雨行动"从试点省份探索转向全国常态化 运行，加快产品上市进程。 （文章来源：第一财经） ...

人民财讯12月4日电，12月3日，推进医疗器械临床研究成果转化暨"春雨行动"工作推进会在广州召开。 会议要求，各参与试点省份要准确把握"春雨行动"的关键环节，继续加强政策宣贯培训，做好项目征集 和评估筛选，积极开展分类指导服务，推动项目匹配对接，完善跨部门协同工作机制，强化注册服务能 力建设，推进以临床价值为导向的医疗器械源头创新，推动"春雨行动"从试点省份探索转向全国常态化 运行，加快产品上市进程。 ...

Core Viewpoint - The "Spring Rain Action" initiative aims to promote the transformation of clinical research results in medical devices, enhancing innovation and industrialization processes in Guangdong's medical device sector [3][4]. Group 1: Policy and Implementation - The "Spring Rain Action" is a significant measure led by the National Medical Products Administration (NMPA) to facilitate the transformation of innovative medical device research results [3]. - Guangdong has established a comprehensive implementation plan for the "Spring Rain Action," which includes setting clear objectives, standards, and mechanisms for clinical research result collection and evaluation [4][5]. - The province's drug regulatory authority has emphasized the importance of early intervention and tailored support for medical device projects to streamline the approval process [5]. Group 2: Industry Status and Achievements - As of June 2025, Guangdong has 8,983 medical device production enterprises and over 1.76 million registered products, leading the nation in both categories [2]. - The province has received approval for 25 innovative drugs and 48 innovative medical devices, showcasing significant breakthroughs in the industry [2]. - Guangdong is home to 250 tertiary hospitals and 50 high-level hospitals, providing a robust platform for clinical trials and research [2]. Group 3: Collaborative Efforts and Future Directions - The training session for the "Spring Rain Action" involved over 60 representatives from various medical and research institutions, fostering collaboration across the medical, academic, and regulatory sectors [6]. - The initiative aims to create a coordinated mechanism involving multiple stakeholders to enhance the transformation of clinical research results into practical applications [6]. - The provincial drug regulatory authority plans to leverage this training as a catalyst for further collaboration and innovation in the medical device field [6].